Abbott Labs Pfizer: Which Is the Bigger Value Trap Now
Abbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
Knowing what to avoid in cryptocurrency investments can save you from costly errors. Stay informed to protect your assets.
16,150 articlesAbbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
SpaceX and Amazon share a blueprint for infrastructure growth, but their earnings paths diverge, forcing investors to...
SOXL surged earlier this year but pulled back sharply in the last month. Two pressure points that will shape its next...
As Verizon nears its July 24 earnings, investors are eyeing a potential near-25% upside driven by steady cash flow, a...
Meta Platforms is gaining momentum in July 2026 as advertisers lean into AI-powered targeting. This piece explains wh...
Chinese memory-maker CXMT gears up for a high-profile $8.6 billion IPO, sparking renewed pressure on U.S. and Asian m...
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A major strategic bet on U.S. manufacturing, taiwan semiconductor commits investing another $100B in the United State...
Dream Finders Homes expands its leadership with Steve Fischer, a banking veteran, joining the board and audit committ...
Markets opened with heavy volatility after reports that iran just crossed trump’s red line, signaling a potential wid...
Two AI hardware names—Astera Labs and Navitas Semiconductor—shine for investors through very different revenue paths....
A mediated settlement ends a years-long dispute between NEXA Lending's CEO and its former partner, yielding full cont...